Cargando…
The management of venous thromboembolism in hospitalized patients with COVID-19
The high incidence of thromboembolic disease, and in particular venous thromboembolism (VTE), has emerged as an important consideration in hospitalized and critically ill patients with coronavirus disease 2019 (COVID-19). The coagulopathy of COVID-19 is postulated to result from interactions of the...
Autor principal: | Spyropoulos, Alex C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Hematology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7448604/ https://www.ncbi.nlm.nih.gov/pubmed/32841342 http://dx.doi.org/10.1182/bloodadvances.2020002496 |
Ejemplares similares
-
COVID-19 coagulopathy vs disseminated intravascular coagulation
por: Levi, Marcel
Publicado: (2020) -
GRNDaD: big data and sickle cell disease
por: Lanzkron, Sophie, et al.
Publicado: (2022) -
Why is AAV FVIII gene therapy not approved by the US Food and Drug Administration yet?
por: Arruda, Valder R.
Publicado: (2021) -
Investigational curative gene therapy approaches to sickle cell disease
por: Williams, David A., et al.
Publicado: (2021) -
Peripheral megakaryocytes sound the alarm in COVID-19
por: Boilard, Eric, et al.
Publicado: (2023)